Skin Beautiful MD Joint Support (Repairs Tissue, Increases Joint Mobility)
This product was developed for people who want to lift and exercise more, but are limited due to joint pain and stiffness.
This product rebuilds, protects and lubricates your joints. It has been shown in clinical studies to reduce joint pain and increase mobility by almost 50% in just the first month.
One ingredient, Fortigel, helps to regrow cartilage in your knees and other joints. It is the most powerful ingredient for joint health that most people have never heard of.
Here is some of the research:
"In a study published in March 2011 by McAlindon and colleagues, the long term effect of FORTIGEL®treatment on the composition of hyaline cartilage in individuals with early knee osteoarthritis was investigated. This prospective, randomized, double-blind, placebo-controlled pilot study was performed at the Tufts Medical Center in cooperation with Harvard University.
Results indicate that oral supplementation of FORTIGEL® has a direct impact on human cartilage tissue. This confirms previous experimental data and clearly demonstrates that specific orally administered collagen peptides can have an influence on cartilage tissue regeneration."
The other main ingredient helps to rebuild your deep dermal layer. Which has incredible cosmetic benefits, which includes the blocking of fat and liquid, which becomes Cellulite in skin with a weak deep dermal layer.
• Balanced, healthy inflammatory response
• Potent antioxidant protection
• Provides building blocks for connective tissue
• Supports joint mobility and function
• Encourages joint repair
• Not associated with the negative side effects of NSAIDs
• High safety and tolerability
• Safe for patients on blood thinners
**This product is also designed to be a COMPLETE REPLACEMENT for Aspirin, Ibuprofen and Acetaminophen. This is important because it is now believed these products are responsible for the deaths of 16,000 arthritis patients a year, 19% of all congestive heart failure hospital admissions and much more. (see references 6-17 at the bottom of this page!!!)
This is a powerful formula that uses the same philosophy as the external Skin Beautiful MD products. The key ingredients are two pre-digested Collagen Peptides that perform 2 essential tasks.
1. Helps build and repair connective tissue.
2. Turns off a set of enzymes that break down connective tissue.
3. Helps maintain tissue hydration.
These peptides are made by a company in Germany, and the formula itself is manufactured in Connecticut. When you take a tablespoon and mix it in water, 7.5 of the 8 grams of the powder are these peptides. The other .5 gram are plant extracts which help reduce pain and swelling in your joints.
==>If you are in pain and want to move more, you'll want to get this, and mix a tablespoon in a glass of water every day. This is gentle on the stomach and is as effective as common osteoarthritis drugs.
This is a very advanced product that is developed by a partner of ours that only manufactures dietary supplements for leading MDs in the US.
Here are 2 videos on the 2 key ingredients in this formula, PLEASE watch BOTH:
1. Levy R, et al. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutr Res. 2009 May;29(5):298-304.
2. Burnett BP, et al. Safety Evaluation of a Combination, Defined Extract of Scutellaria baicalensis and Acacia catechu. J Food Biochem. 2007;31:797-825.
3. Burnett BP, et al. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food. 2007 Sep;10(3):442-51.
4. Adam M, What effects do gelatine preparations have? Therapy of osteoarthritis (in German), Therapiewoche 1991, 41, 2456-2461.
5. Clark, Sebastianelli et al., 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain, Current Medical Research and Opinion, Vol. 24, No. 5, 2008, 1485 – 1496.
6. Edward J. Frech and Mae F. Go. Treatment and chemoprevention of NSAID-associated gastrointestinal complications. Therapeutics and Clinical Risk Management, 2009, pp. 65-73.
7. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am. J. Med. 1998 105(1B):31S–38S.
8. Vonkeman HE and van de Laar MAFJ. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010 39(4):294– 312.
9. Back M, et al. Cyclooxygenase2 inhibitors and cardiovascular risk in a nationwide cohort study after the withdrawal of rofecoxib. Eur Heart J. 2011;21. [Epub ahead of print]
10. Moodley I. Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr. 2008 MarApr 19(2):1027.
11. Belknap SM. NSAIDs were associated with increased risk for mortality, regardless of time since first MI. Ann Intern Med. 2013 Jan 15;158(2):JC10.
12. Roubille C, et al. Cardiovascular adverse effects of anti-inflammatory drugs. Antiinflamm Antiallergy Agents Med Chem. 2012 Dec 31.
13. Arch Intern Med. 2000;160(6):777-784. doi:10.1001/archinte.160.6.777.
14. Singh Gurkirpal, MD, Recent Considerations in Nonsteroidal Anti-Inflammatory Drug Gastropathy, The American Journal of Medicine, July 27, 1998, p. 31S
15. Wolfe M. MD, Lichtenstein D. MD, and Singh Gurkirpal, MD, Gastrointestinal Toxicity of Nonsteroidal Anti-inflammatory Drugs, The New England Journal of Medicine, June 17, 1999, Vol. 340, No. 24, pp. 1888-1889.
16. Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005 42(6):1364–72.
17. Bessems JG and Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 2001 31(1):55–138.
18. Patrício JP, et al. Relative Cardiovascular and Gastrointestinal Safety of Non-selective Non-steroidal Anti-inflammatory Drugs Versus Cyclo-oxygenase-2 Inhibitors: Implications for Clinical Practice. Clin Drug Investig. 2013 Jan 22.
19. T.E. McAlindon, M. Nuite, N. Krishnan, R. Ruthazer, L.L. Price, D. Burstein, J. Griffith, K. Flechsenhar, Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. Osteoarthritis and Cartilage Vol 19, Issue 4, April 2011, P. 399- 405.